PMID- 32636395 OWN - NLM STAT- MEDLINE DCOM- 20200908 LR - 20210707 IS - 2041-1723 (Electronic) IS - 2041-1723 (Linking) VI - 11 IP - 1 DP - 2020 Jul 7 TI - IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms. PG - 3390 LID - 10.1038/s41467-020-17095-7 [doi] LID - 3390 AB - Immunoglobulin (Ig) gene rearrangements and oncogenic translocations are routinely assessed during the characterization of B cell neoplasms and stratification of patients with distinct clinical and biological features, with the assessment done using Sanger sequencing, targeted next-generation sequencing, or fluorescence in situ hybridization (FISH). Currently, a complete Ig characterization cannot be extracted from whole-genome sequencing (WGS) data due to the inherent complexity of the Ig loci. Here, we introduce IgCaller, an algorithm designed to fully characterize Ig gene rearrangements and oncogenic translocations from short-read WGS data. Using a cohort of 404 patients comprising different subtypes of B cell neoplasms, we demonstrate that IgCaller identifies both heavy and light chain rearrangements to provide additional information on their functionality, somatic mutational status, class switch recombination, and oncogenic Ig translocations. Our data thus support IgCaller to be a reliable alternative to Sanger sequencing and FISH for studying the genetic properties of the Ig loci. FAU - Nadeu, Ferran AU - Nadeu F AUID- ORCID: 0000-0003-2910-9440 AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. nadeu@clinic.cat. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. nadeu@clinic.cat. FAU - Mas-de-Les-Valls, Rut AU - Mas-de-Les-Valls R AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. FAU - Navarro, Alba AU - Navarro A AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. FAU - Royo, Romina AU - Royo R AD - Barcelona Supercomputing Center (BSC), Barcelona, Spain. FAU - Martin, Silvia AU - Martin S AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. FAU - Villamor, Neus AU - Villamor N AUID- ORCID: 0000-0001-6538-4111 AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. FAU - Suarez-Cisneros, Helena AU - Suarez-Cisneros H AD - Unitat de Genomica, IDIBAPS, Barcelona, Spain. FAU - Mares, Roso AU - Mares R AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. FAU - Lu, Junyan AU - Lu J AD - European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. FAU - Enjuanes, Anna AU - Enjuanes A AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Unitat de Genomica, IDIBAPS, Barcelona, Spain. FAU - Rivas-Delgado, Alfredo AU - Rivas-Delgado A AUID- ORCID: 0000-0003-0385-3415 AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. FAU - Aymerich, Marta AU - Aymerich M AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. FAU - Baumann, Tycho AU - Baumann T AD - Hospital Clinic of Barcelona, Barcelona, Spain. FAU - Colomer, Dolors AU - Colomer D AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. AD - Universitat de Barcelona, Barcelona, Spain. FAU - Delgado, Julio AU - Delgado J AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. FAU - Morin, Ryan D AU - Morin RD AUID- ORCID: 0000-0003-2932-7800 AD - Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada. AD - Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada. FAU - Zenz, Thorsten AU - Zenz T AUID- ORCID: 0000-0001-7890-9845 AD - Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. FAU - Puente, Xose S AU - Puente XS AUID- ORCID: 0000-0001-9525-1483 AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, Oviedo, Spain. FAU - Campbell, Peter J AU - Campbell PJ AUID- ORCID: 0000-0002-3921-0510 AD - Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK. FAU - Bea, Silvia AU - Bea S AUID- ORCID: 0000-0001-7192-2385 AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Universitat de Barcelona, Barcelona, Spain. FAU - Maura, Francesco AU - Maura F AUID- ORCID: 0000-0002-5017-1620 AD - Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK. AD - Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Campo, Elias AU - Campo E AUID- ORCID: 0000-0001-9850-9793 AD - Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. AD - Hospital Clinic of Barcelona, Barcelona, Spain. AD - Universitat de Barcelona, Barcelona, Spain. LA - eng GR - P01 CA229100/CA/NCI NIH HHS/United States GR - P30 CA008748/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20200707 PL - England TA - Nat Commun JT - Nature communications JID - 101528555 SB - IM MH - Algorithms MH - Cohort Studies MH - *Genes, Immunoglobulin MH - Genome, Human MH - Hematologic Neoplasms/genetics/immunology MH - High-Throughput Nucleotide Sequencing MH - Humans MH - Immunoglobulin Class Switching MH - In Situ Hybridization, Fluorescence/*methods MH - Lymphoma, B-Cell/genetics/immunology MH - *Oncogenes MH - Software MH - *Translocation, Genetic MH - Whole Genome Sequencing PMC - PMC7341758 COIS- The authors declare no competing interests. EDAT- 2020/07/09 06:00 MHDA- 2020/09/09 06:00 PMCR- 2020/07/07 CRDT- 2020/07/09 06:00 PHST- 2019/11/13 00:00 [received] PHST- 2020/06/11 00:00 [accepted] PHST- 2020/07/09 06:00 [entrez] PHST- 2020/07/09 06:00 [pubmed] PHST- 2020/09/09 06:00 [medline] PHST- 2020/07/07 00:00 [pmc-release] AID - 10.1038/s41467-020-17095-7 [pii] AID - 17095 [pii] AID - 10.1038/s41467-020-17095-7 [doi] PST - epublish SO - Nat Commun. 2020 Jul 7;11(1):3390. doi: 10.1038/s41467-020-17095-7.